Discovery of a Novel, Selective and Irreversible Inhibitor (Abivertinib) of Mutated EGFR and T790M-induced Resistance for the Treatment of NSCLC
Three chemical series of heterocyclic small molecules were designed and synthesized as the 3rd generation EGFR inhibitors. Detailed structure-activity relationship (SAR) studies and lead optimization (from 1a to 4d) were descripted. With the support of molecular modeling and evaluation through bioch...
Saved in:
Main Authors: | Long Mao (Author), Wei Tang (Author), Xiaoying Zhang (Author), Jia Liu (Author), Yile Chen (Author), Yuning Hua (Author), Bojie Weng (Author), Xiaopeng Mo (Author), Yimei Bao (Author), Li Teng (Author), Lijun Xu (Author), Yuren Zhang (Author), Jian Wu (Author), Guanglin Zhou (Author), Bin Liang (Author), Changxu Xu (Author), Biao Xi (Author), Li Zhao (Author), Rongda Xu (Author), Che Fang (Author), Wanhong Xu (Author), Xiaobo Wang (Author), Xiao Xu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SH-1028, An Irreversible Third-Generation EGFR TKI, Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer
by: Luwei Han, et al.
Published: (2021) -
Is electrocardiogram-gated irreversible electroporation still effective in liver ablation? A validation study in swine liver irreversible electroporation model
by: Edward Wolfgang Lee, et al.
Published: (2023) -
Impact of NSCLC metabolic remodeling on immunotherapy effectiveness
by: Lulu Lv, et al.
Published: (2022) -
Knockdown of EIF4G1 in NSCLC induces CXCL8 secretion
by: Ziyang He, et al.
Published: (2024) -
Identification of solamargine as a cisplatin sensitizer through phenotypical screening in cisplatin-resistant NSCLC organoids
by: Yi Han, et al.
Published: (2022)